cetyltrimethylammonium ion has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cone, RE; Georgiou, GM; Little, CH; Marceglia, A; Mazza, D; Ogedgebe, H | 1 |
| Chen, CH; Hu, CW; Huang, FM; Lee, CJ; Liu, JY; Pan, YR; Wu, TK | 1 |
2 other study(ies) available for cetyltrimethylammonium ion and transforming growth factor beta
| Article | Year |
|---|---|
Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.
Topics: Adult; Antibodies, Fungal; Antibody Specificity; Antigens, Fungal; Candidiasis, Vulvovaginal; Cetrimonium; Cetrimonium Compounds; Detergents; Female; Humans; Immunoglobulin G; In Vitro Techniques; Interferon-gamma; Lymphocyte Activation; Mannans; T-Lymphocytes; Th2 Cells; Transforming Growth Factor beta | 2000 |
Cetrimonium Bromide Inhibits Cell Migration and Invasion of Human Hepatic SK-HEP-1 Cells Through Modulating the Canonical and Non-canonical TGF-β Signaling Pathways.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cetrimonium; Humans; Liver Neoplasms; Neoplasm Invasiveness; Signal Transduction; Transforming Growth Factor beta | 2019 |